Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion type Assertion NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_head.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion description "[In order to clarify the significance of p16 gene (CDKN2) inactivation and its disease specificity among hematopoietic tumors, configurations of the p16 gene as well as those of the adjacent p15 and interferon alpha (IFN alpha) genes were examined in primary hematopoietic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_provenance.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion evidence source_evidence_literature NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_provenance.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion SIO_000772 9209389 NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_provenance.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion wasDerivedFrom befree-20140225 NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_provenance.
- NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_assertion wasGeneratedBy ECO_0000203 NP470019.RAN3tdFbYeirLN5cOMg0FtahnSDGLxkzNIbjk7_2KU920130_provenance.